BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14511113)

  • 1. Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi.
    Brown LR; Harris DA
    J Neurochem; 2003 Oct; 87(2):353-63. PubMed ID: 14511113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper stimulates endocytosis of the prion protein.
    Pauly PC; Harris DA
    J Biol Chem; 1998 Dec; 273(50):33107-10. PubMed ID: 9837873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.
    Brim S; Groschup MH; Kuczius T
    PLoS One; 2016; 11(4):e0153931. PubMed ID: 27093554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions disturb post-Golgi trafficking of membrane proteins.
    Uchiyama K; Muramatsu N; Yano M; Usui T; Miyata H; Sakaguchi S
    Nat Commun; 2013; 4():1846. PubMed ID: 23673631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.
    Shyng SL; Lehmann S; Moulder KL; Harris DA
    J Biol Chem; 1995 Dec; 270(50):30221-9. PubMed ID: 8530433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.
    Kiachopoulos S; Heske J; Tatzelt J; Winklhofer KF
    Traffic; 2004 Jun; 5(6):426-36. PubMed ID: 15117317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking of prion proteins through a caveolae-mediated endosomal pathway.
    Peters PJ; Mironov A; Peretz D; van Donselaar E; Leclerc E; Erpel S; DeArmond SJ; Burton DR; Williamson RA; Vey M; Prusiner SB
    J Cell Biol; 2003 Aug; 162(4):703-17. PubMed ID: 12925711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prions and exosomes: from PrPc trafficking to PrPsc propagation.
    Porto-Carreiro I; Février B; Paquet S; Vilette D; Raposo G
    Blood Cells Mol Dis; 2005; 35(2):143-8. PubMed ID: 16099696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein.
    Magalhães AC; Silva JA; Lee KS; Martins VR; Prado VF; Ferguson SS; Gomez MV; Brentani RR; Prado MA
    J Biol Chem; 2002 Sep; 277(36):33311-8. PubMed ID: 12070160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbed vesicular trafficking of membrane proteins in prion disease.
    Uchiyama K; Miyata H; Sakaguchi S
    Prion; 2013; 7(6):447-51. PubMed ID: 24335150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
    Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
    Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of glypican-1 autoprocessing in scrapie infection.
    Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
    Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
    Leach SP; Salman MD; Hamar D
    Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trafficking, turnover and membrane topology of PrP.
    Harris DA
    Br Med Bull; 2003; 66():71-85. PubMed ID: 14522850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
    Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
    PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the physiological function of cellular prion protein.
    Martins VR; Mercadante AF; Cabral AL; Freitas AR; Castro RM
    Braz J Med Biol Res; 2001 May; 34(5):585-95. PubMed ID: 11323744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrPc on the road: trafficking of the cellular prion protein.
    Prado MA; Alves-Silva J; Magalhães AC; Prado VF; Linden R; Martins VR; Brentani RR
    J Neurochem; 2004 Feb; 88(4):769-81. PubMed ID: 14756798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.